Testing Cyclosporine for Moderate to Severe Brain Injury
Treatments studied
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study tests a drug called cyclosporine to see if it can help people with moderate to severe traumatic brain injury. You may be eligible if you have a brain injury seen on CT and can start treatment within 24 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a head injury and need a CT scan.
- Your Glasgow Coma Scale score before any sedation was between 3 and 12 (this means you were not fully conscious).
- A CT scan shows a brain bruise (contusion) or tiny blood vessel injury.
- You can start the study treatment within 24 hours of the injury.
- You do not have serious kidney, liver, or other diseases that would make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational treatment to improve outcomes after a recent non-penetrating traumatic brain injury (like a fall or car crash). It uses early CT/MRI imaging and a blood test soon after injury to see who benefits and how well the treatment works.
This trial tests whether a steroid called methylprednisolone, given early after a head injury, helps reduce brain swelling and improve recovery. It is for people with moderate to severe traumatic brain injury who can start treatment within 12 hours.
This trial tests whether steroids can help reduce brain swelling in people with mild to moderate traumatic brain injury. It is for patients who have a bruise on the brain seen on a CT scan and signs of increased pressure in the head.
This study looks at patients with severe traumatic brain injury (TBI) who already need brain pressure or oxygen monitoring. Doctors want to see if certain tests can help predict how well someone might recover.
This Phase 2 trial is testing a combination medication strategy to improve outcomes after severe traumatic brain injury that needs emergency brain surgery soon after the injury. It may help by affecting how injured brain cells respond, aiming to improve survival or recovery.
This study tests a drug called Angiotensin (1-7) to see if it helps people recover from moderate to severe traumatic brain injury. It may reduce damage and improve healing when given shortly after the injury.
Hear when a new Traumatic Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.